Clinical Trial Update: Methylphenidate in Childhood Apraxia of Speech [Phase 2]

View source ↗

Summary

This update reports that a Phase 2 clinical trial evaluating methylphenidate for childhood apraxia of speech has completed. The snippet does not provide trial r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Apraxia of Speech

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Childhood Apraxia of Speech | Phase 2 | Status: COMPLETED